Patents by Inventor Matthew ZAREK

Matthew ZAREK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibrinogen-based tissue adhesive patches
    Patent number: 11071805
    Abstract: A novel fibrinogen-based tissue adhesive patch is disclosed. The patch comprises a backing made from a non-permeable biocompatible polymer film into which a fibrinogen-based sealant is incorporated. In preferred embodiments of the invention, the biocompatible polymer film comprises units of a biocompatible block copolymer such as a polyethylene glycol-polycaprolactone-DL-lactide copolymer connected by urethane linkages, and the fibrinogen-based sealant comprises fibrinogen, thrombin, and CaCl2. In contrast to similar patches known in the art, the polymer backing serves to seal the tissue to which the patch is applied, and the sealant acts only to bind the patch to the affected tissue. The patch does not include any mesh, woven, or non-woven component. Methods of production and use of the patch are also disclosed.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: July 27, 2021
    Assignee: SEALANTIUM MEDICAL LTD.
    Inventors: Orgad Laub, Daniel Cohn, Eran Cohen, Matthew Zarek
  • FIBRINOGEN-BASED TISSUE ADHESIVE PATCHES
    Publication number: 20180326115
    Abstract: A novel fibrinogen-based tissue adhesive patch is disclosed. The patch comprises a backing made from a non-permeable biocompatible polymer film into which a fibrinogen-based sealant is incorporated. In preferred embodiments of the invention, the biocompatible polymer film comprises units of a biocompatible block copolymer such as a polyethylene glycol-polycaprolactone-DL-lactide copolymer connected by urethane linkages, and the fibrinogen-based sealant comprises fibrinogen, thrombin, and CaCl2. In contrast to similar patches known in the art, the polymer backing serves to seal the tissue to which the patch is applied, and the sealant acts only to bind the patch to the affected tissue. The patch does not include any mesh, woven, or non-woven component. Methods of production and use of the patch are also disclosed.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Inventors: Orgad LAUB, Daniel COHN, Eran COHEN, Matthew ZAREK
  • FIBRINOGEN-BASED TISSUE ADHESIVE PATCHES
    Publication number: 20160067371
    Abstract: A novel fibrinogen-based tissue adhesive patch is disclosed. The patch comprises a backing made from a non-permeable biocompatible polymer film into which a fibrinogen-based sealant is incorporated. In preferred embodiments of the invention, the fibrinogen-based sealant comprises fibrinogen, thrombin, and CaCl2. The polymer backing serves to seal the tissue to which the patch is applied, and the sealant acts only to bind the patch to the affected tissue. The patch does not include any mesh or woven component. Methods of production of the patch are also disclosed.
    Type: Application
    Filed: April 10, 2014
    Publication date: March 10, 2016
    Applicant: SEALANTIUM MEDICAL LTD
    Inventors: Orgad LAUB, Daniel COHN, Eran COHEN, Matthew ZAREK